Unlock the Potential of the Human Microbiome

08/09/2020 - 11/09/2020
Barcelona, Spain

From 8 to 11 of September 2020, Barcelona, Spain will host The Gut Week Summit 2020. This 2nd Annual event brings together leading scientists, physicians, and senior leaders to explore the potential insights into the Microbiota–Gut–Brain Axis, the Human Microbiome Market that exhibits significant potential in the near future and skin’s microbiome that has the potential to revolutionize the beauty and personal care industry.

40+ expert speakers, 40+ case studies demonstrating disease causation of the gut-brain axis and Skin Microbiome

The ability of gut microbiota to communicate with the brain is emerging as an exciting concept in health and disease. Mounting evidence, mostly from rodent studies, suggests that gut microbes help shape normal neural development, brain biochemistry, and behaviour.

The Gut Week Summit 2020 is set to be the “must-attend” meeting for anyone interested in unlocking the potential of the Human Microbiome, and translating it into safe, effective and commercially viable therapeutics.

The Gut Week Summit 2020 will be dedicated to help large pharma, biotech, academics and clinicians exploring and understand the Human Microbiome Market, GBA in demonstrating disease causation and changing perceptions of bacteria in the Skin Microbiome. Over the last decade, the microbiome has become one of the trendiest areas of biology, and the research has made clear that the microbiome is fundamental to overall health.



8-9 SEP 2020

  • The influence of the intestinal microbiome on vaccine responses
  • Effectively understand and manipulate the Gut-Brain Axis
  • Learn about the microbiota and their metabolites and neurotransmitters production
  • Influence of the microbiota on vaccine effectiveness
  • Discover tools and technologies to help investigate the GBA
  • Build predictive pre-clinical models in the gut-brain axis
  • The importance of the gut–brain axis in emotional, behavioral and development disorders
  • Stress related bowel disease: gut-brain axis in IBD and IBS
  • Develop commercially viable therapeutics and nutritional products
  • Probiotics, prebiotics, synbiotics and psychobiotics [/su_column]

10-11 SEP 2020

  • Skin Disease & Microbiome
  • The impact of environment and age on shaping our individual microbiota
  • The skin microbiome: Current perspectives and future challenges
  • Preservative Free-Formulation, Manufacturing and Packing
  • The Skin Microbiome & Big Data
  • Metabolites & Skin Microbiome
  • The Development and Maintenance of the Skin Barrier
  • Human Skin Microbiome: From metagenomes to therapeutics
  • Commercialization of Microbiome-Based Personal Care
  • Regulation considerations for dermatology & cosmetics
  • Academic-Industry Collaborations[/su_column][/su_row]


  • 4D Pharma Research
  • Amabiotics
  • AMC
  • Amylgen
  • APC Microbiome Ireland
  • Astel Medica
  • AstraZeneca
  • Biocodex
  • Biose
  • Bloom Science
  • Chain Biotech
  • Columbia University Medical Center
  • Danone Produits Frais
  • Exden
  • Finch Therapeutics
  • Greenmed
  • Grenoble Faculty of Medicine & Hospital
  • Holobiome
  • ImmuneBiotech AB
  • Institute of Marine Research
  • Jackson Laboratory
  • Karolinska Institutet
  • Kilee Patchell-Evans Autism
  • Kobiolabs
  • L’Oreal Advanced Research
  • Lallemand Health Solution
  • Lesaffre Human Care
  • LNC Therapeutics
  • Lundbeck
  • Maastricht University
  • MP Healthcare
  • NeribiOm
  • Nestlé
  • Neurosciences Paris Saclay
  • Nicklaus Children’s Hospital
  • Northumbria University
  • Novo Nordisk Foundation
  • Örebro University
  • Pharmabiotic Research
  • PiLeJe
  • PRI: Microbiotic Medicinal Products
  • ProDigest
  • Quay Pharmaceuticals
  • Seventure Partners
  • TargEDys
  • Texas Children’s Microbiome
  • UCB Biopharma
  • UCLA
  • University Novi Sad
  • University of Melbourne
  • University of Michigan
  • Winclove Probiotics


  • Scientific Project Leader
  • Head Search & Evaluation Neuroscience
  • Molecular Toxicology
  • Nutrition & Health
  • Laboratory Director
  • Neuroscientist
  • Modeling and Data Specialist
  • Microbiome and Lipid Biology
  • Genome Editing
  • Business Development
  • Associate Research Director
  • Strategy & Business
  • IVD Assay Development
  • Safety Risk Lead
  • Skin & Health
  • Preclinical Group Leader
  • Pharmacovigilance
  • Drug Discovery
  • Research Investigator
  • Regulatory Affairs

Register at the Official Website